AI therapeutics company Basecamp Research raises $140 million Series C
The London startup designs medicines with AI models trained on proprietary biological data.
Basecamp Research Issuer · S32 Lead investor · NVIDIA Investor · Menlo Ventures Investor · Catalio Capital Management Investor · European Tech Collective Investor · Inception Fund Investor · King Philanthropies Investor · NATO Innovation Fund Investor · PostScriptum Investor · redalpine Investor · The Rockefeller Foundation Investor · Singular Investor · Sovereign AI Investor · True Ventures Investor